The Boston-based company developed Dreem 3S with integrated machine learning algorithms. The advanced wearable headband captures EEG data from the brain to monitor sleep architecture and aid in diagnosing disturbed sleep.
Beacon Biosignals says its easy-to-use device makes it simple for patients to participate in clinically validated EEG-based sleep monitoring. By using it at home, patients can unlock new insights into sleep physiology. The company acquired the platform by buying the R&D business of Dreem in July.
Traditional research for these types of therapies requires patients to spend nights in sleep laboratories or use less-precise wrist actigraphy. Dreem 3S — the first dry-EEG medical device of its kind — allows for convenient data collection at home. Patients use…